CD
LLY icon

Christopher Davis’s Eli Lilly LLY Stock Holding History

Christopher Davis’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-298,809
Closed -$14.7M – 202
2013
Q2 		$14.7M Buy
+298,809
New +$16.3M 0.04% 107

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Christopher Davis's LLY Position: Q3 2013 in Review

Christopher Davis sold out of Eli Lilly (LLY) in Q3 2013, closing a stake of 298,809 shares — an estimated $14.7M sold.

Christopher Davis first reported a position in LLY in Q2 2013 and held it in 1 quarter. The position peaked at $14.7M in Q2 2013. 974 funds tracked by Wall St. Rank hold LLY as of Q3 2013.

  • Christopher Davis reported no remaining Eli Lilly position as of Q3 2013 after selling out during the quarter.
  • Christopher Davis sold 298,809 Eli Lilly shares in Q3 2013, an estimated $14.7M.
  • Christopher Davis first reported a position in Eli Lilly in Q2 2013 and held it in 1 quarter.
  • Christopher Davis's Eli Lilly position peaked at $14.7M in Q2 2013.
  • 974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2013.

Based on Davis Selected Advisers's 13F filing for Q3 2013, filed 12 Nov 2013.